Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Estrogens, conjugated - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for estrogens, conjugated and what is the scope of estrogens, conjugated freedom to operate?

Estrogens, conjugated
is the generic ingredient in twelve branded drugs marketed by Wyeth Pharms Inc, Teva Womens, Teva Branded Pharm, Medpointe Pharm Hlc, and Wyeth Ayerst, and is included in ten NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, conjugated. Ten suppliers are listed for this compound.

Summary for Generic Name: estrogens, conjugated

Tradenames:12
Patents:3
Applicants:5
NDAs:10
Drug Master File Entries: see list3
Suppliers / Packagers: see list10
Clinical Trials: see list99
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estrogens, conjugated at DailyMed

Pharmacology for Ingredient: estrogens, conjugated

Ingredient-typeEstrogens, Conjugated (USP)
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc
MILPREM-400
estrogens, conjugated; meprobamate
TABLET;ORAL011045-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva Branded Pharm
CENESTIN
estrogens, conjugated synthetic a
TABLET;ORAL020992-001Jun 21, 2002DISCNNoNo► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-003Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe
Medpointe Pharm Hlc
MILPREM-200
estrogens, conjugated; meprobamate
TABLET;ORAL011045-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva Branded Pharm
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-003May 10, 2004DISCNNoNo6,855,703► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot